We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HealthPeak Boosts Flexibility With $3B Revolving Credit Facility
Read MoreHide Full Article
Healthpeak Properties, Inc.’s (DOC - Free Report) operating partnership has amended and extended its revolving credit facility amounting to $3 billion. Furthermore, conforming amendments are made to its outstanding term loans associated with this credit facility.
The facility is scheduled to mature in January 2029, with the option for two six-month extensions, subject to certain conditions. Based on current credit ratings of Healthpeak, the interest rate for the credit facility is set at an annual rate equivalent to SOFR plus 77.5 basis points (bps), in addition to a facility fee of 15 bps per annum on the entire revolving commitment.
Summing-Up Healthpeak
Healthpeak is well-poised to gain from its portfolio of top-quality healthcare real estate assets in the high barrier-to-entry markets of the United States. Solid demand for lab assets amid increasing need for drug innovation and developments is likely to drive its lab portfolio’s growth. Its continuing care retirement community portfolio is poised to gain from the rise in senior citizens’ healthcare spending. Encouraging capital-recycling moves bode well for long-term growth.
The successful transaction, as noted above, highlights the strength of its balance sheet and bolsters Healthpeak's growth initiatives while affirming the company’s ongoing dedication to generate long-term value for its shareholders.
In the past six months, shares of this Zacks Rank #3 (Hold) company have gained 13.2% compared with the industry’s growth of 13.5%.
The Zacks Consensus Estimate for Welltower’s 2024 FFO per share is pinned at $4.26, implying year-over-year growth of 17%.
The Zacks Consensus Estimate for Alpine Income’s 2024 FFO per share is pegged at $1.70, indicating an increase of 15.7% from the year-ago reported figure.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HealthPeak Boosts Flexibility With $3B Revolving Credit Facility
Healthpeak Properties, Inc.’s (DOC - Free Report) operating partnership has amended and extended its revolving credit facility amounting to $3 billion. Furthermore, conforming amendments are made to its outstanding term loans associated with this credit facility.
The facility is scheduled to mature in January 2029, with the option for two six-month extensions, subject to certain conditions. Based on current credit ratings of Healthpeak, the interest rate for the credit facility is set at an annual rate equivalent to SOFR plus 77.5 basis points (bps), in addition to a facility fee of 15 bps per annum on the entire revolving commitment.
Summing-Up Healthpeak
Healthpeak is well-poised to gain from its portfolio of top-quality healthcare real estate assets in the high barrier-to-entry markets of the United States. Solid demand for lab assets amid increasing need for drug innovation and developments is likely to drive its lab portfolio’s growth. Its continuing care retirement community portfolio is poised to gain from the rise in senior citizens’ healthcare spending. Encouraging capital-recycling moves bode well for long-term growth.
The successful transaction, as noted above, highlights the strength of its balance sheet and bolsters Healthpeak's growth initiatives while affirming the company’s ongoing dedication to generate long-term value for its shareholders.
In the past six months, shares of this Zacks Rank #3 (Hold) company have gained 13.2% compared with the industry’s growth of 13.5%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks from the broader REIT sector are Welltower (WELL - Free Report) and Alpine Income Property Trust (PINE - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Welltower’s 2024 FFO per share is pinned at $4.26, implying year-over-year growth of 17%.
The Zacks Consensus Estimate for Alpine Income’s 2024 FFO per share is pegged at $1.70, indicating an increase of 15.7% from the year-ago reported figure.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.